SOFIA (Bulgaria), November 4 (SeeNews) – The board of Bulgarian veterinary drug maker Biovet [BUL:53B] said on Friday that the joint buyout bid of its majority owner Huvepharma and minority shareholder Opportunity 2009 is a fair offer, in line with Biovet's expected performance.